Metraipolis › archive › dc_d0a7945dcd6d

Neurotherapeutics across blood-brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease — Europe PMC PMID:41079713

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41079713
DOI
10.3389/fphar.2025.1616144
License (as archived)
solo-consultazione
Archived
2026-11-09T17:52:17.858Z
SHA-256 of the archived text
0380150a18dd933f5b0d74d3765dee601a8aaebbbe7db1cf5b1683fcc33effe5
Stable URL of this page
https://metraipolis.com/documento/dc_d0a7945dcd6d

How to cite

Neurotherapeutics across blood-brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease — Europe PMC PMID:41079713 — Europe PMC (en), https://europepmc.org/article/MED/41079713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0a7945dcd6d (Metraipolis archive dc_d0a7945dcd6d, sha256 0380150a18dd933f5b0d74d3765dee601a8aaebbbe7db1cf5b1683fcc33effe5)
BibTeX
@misc{dcd0a7945dcd6d,
  title = {Neurotherapeutics across blood-brain barrier: screening of BBB-permeable and CNS-active molecules for neurodegenerative disease — Europe PMC PMID:41079713},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41079713},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0a7945dcd6d; sha256 0380150a18dd933f5b0d74d3765dee601a8aaebbbe7db1cf5b1683fcc33effe5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41079713. Agents can read the archived copy with the MCP tool read_document.